HAMP and inflammatory bowel disease: Consequently, prescription of infliximab is believed to improve anemia in IBD individuals and we may, thus, hypothesize that patients with elevated hepcidin values and anemia might benefit more from the use of these drugs and be selected as appropriate candidates for the prescription of this monoclonal antibody (Shu et al., 2019).